Fluorescein (Funduscein)

3996  relevant articles (106 outcomes, 405 trials/studies) found for this Drug

Funduscein; Alcon Brand of Fluorescein Sodium; Allergan Brand of Fluorescein Sodium; C.I. 45350; Cahill May Roberts Brand of Fluorescein Sodium; Chauvin Brand of Fluorescein Sodium; Colircusi Fluoresceina; D & C Yellow No. 7; D & C Yellow No. 8; D and C Yellow No. 7; D and C Yellow No. 8; D&C Yellow No. 7; D&C Yellow No. 8; Diba Brand of Fluorescein Sodium; Diofluor; Dioptic Brand of Fluorescein Sodium; Disodium Fluorescein; Fluor-I-Strip A.T.; Fluorescein Dipotassium Salt; Fluorescein Disodium Salt; Fluorescein Monosodium Salt; Fluorescite; Fluorescéine sodique Faure; Fluorets; Ful-Glo; Minims Fluorescein Sodium; Minims Fluoresceine; Minims Stains; Novartis Brand of Fluorescein Sodium; Optifluor Diba; Smith & Nephew Brand of Fluorescein Sodium; Sola/Barnes-Hind Brand of Fluorescein Sodium; Uranine; Wyeth Brand of Fluorescein Sodium; Dipotassium Salt, Fluorescein; Disodium Salt, Fluorescein; Fluor I Strip A.T.; Fluorescein Sodium, Minims; Fluorescein, Disodium; Fluorescein, Sodium; Fluoresceina, Colircusi; Fluoresceine, Minims; Ful Glo; Monosodium Salt, Fluorescein; Sodium, Fluorescein; Sola/Barnes Hind Brand of Fluorescein Sodium; Fluorescein Sodium; Sodium Fluorescein

Relationship Network

Drug Context: Research Results

Experts

1.	Arend, Oliver: 4 articles (01/2006 - 02/2004)
2.	Remky, Andreas: 4 articles (01/2006 - 02/2004)
3.	Plange, Niklas: 4 articles (01/2006 - 02/2004)
4.	Remky, A: 4 articles (08/2004 - 04/2001)
5.	Arend, O: 4 articles (08/2004 - 04/2001)
6.	Plange, N: 4 articles (08/2004 - 04/2001)
7.	Kaup, Marion: 3 articles (01/2006 - 02/2004)
8.	Lanigan, Bernadette: 2 articles (01/2008 - 03/2006)
9.	O'Keefe, Michael: 2 articles (01/2008 - 03/2006)
10.	Fardeau, Christine: 2 articles (11/2007 - 04/2007)

Related Diseases

1.	Macular Edema 12/01/2004 - "RESULTS: Fluorescein angiography showed marked improvement of macular edema in 4 eyes (21.0%), mild improvement in 10 eyes (52.6%) and no change in 5 eyes (26.3%); no patient had worsening of macular edema. " 09/01/1983 - "Fluorescein angiographic findings varied considerably with some patients showing an improvement with continued cystoid macular edema. " 11/01/2005 - "Postoperative fundus fluorescein angiogram showed dilated and improved perfusion with decreased macular edema in both cases. " 06/01/2005 - "Twelve of 30 (40%) cases in the MP group and 24 of 30 (80%) cases in the FL + PSTI group showed clinical improvement in macular edema according to the stereoscopic evaluation of fundus and fluorescein angiography (P = 0.003). " 03/01/2004 - "The follow-up was 3 - 5 months range, All patients had improvement in the retina and macular edema and the appearance of the fundus as documented by photography, fluorescein angiography. " Order ALL the reference details at left...
2.	Hemorrhage 11/01/2003 - "RESULTS: Three eyes had an improvement in visual acuity of more than 2 lines, and fluorescein angiography showed stabilization of the membrane and reduction of the hemorrhages and subretinal fluid at the last follow-up. " 09/01/1997 - "Fluorescein angiography was more effective, in general, than ICG angiography in detecting CNV; however, CNVs with subretinal hemorrhage (2 of 35 sites) were visible only with ICG angiography. " 10/01/2007 - "Improved visual acuity (VA) and cessation of fluorescein leakage was achieved within 18 months in all eyes; however, subretinal hemorrhage and subfoveal fluid recurred due to new or recurrent PCV. " 09/15/1988 - "Fluorescein angiography helped differentiate these subretinal hemorrhages from those caused by subretinal neovascularization." 09/01/1997 - "This study confirms that only ICG angiography can identify CNV hidden by subretinal hemorrhage, although fluorescein angiography is otherwise superior. " Order ALL the reference details at left...
3.	Inflammation 01/01/2007 - "Disappearance of subjective symptoms, increase in best corrected visual acuity, tear meniscus, tear breakup time, decrease in inflammation, fluorescein staining and improvement in impression cytology were measured. " 03/01/1990 - "Elimination or significant reduction of fluorescein leakage within a treatment group constituted increased efficacy in controlling inflammation. " 12/01/2002 - "Treatment was considered effective in 32 patients (52.45%): improvement of visual acuity (more than two lines) or control of inflammation on fluorescein angiography. " 07/01/2005 - "Success was judged by the composite clinical end point of visual acuity, control of intraocular inflammation, ability to taper concomitant medication therapy, and improvement in inflammatory signs on fluorescein angiography and/or ocular coherence tomography. " 10/01/1979 - "To study the vascular changes in inflammatory diseases of the cornea 22 patients with various corneal inflammations were examined by means of anterior segment fluorescein angiography. " Order ALL the reference details at left...
4.	Choroidal Neovascularization 12/01/2006 - "PURPOSE: In this study, the authors sought to develop and characterize techniques for measuring changes in choroidal neovascularization (CNV) lesion size and fluorescence over time for quantitative analysis of fluorescein angiograms. " 02/01/2006 - "OBJECTIVES: To compare topographic features of surgically excised subfoveal choroidal neovascularization with preoperative and postoperative fluorescein angiographic features from Submacular Surgery Trials (SST) patients, and to compare histological and angiographic features with preoperative and postoperative visual acuities (VAs). " 11/01/2004 - "METHODS: Eligible patients 18 years or older had subfoveal choroidal neovascularization (new or recurrent) that included a classic component on fluorescein angiography and best-corrected visual acuity of 20/50 to 20/800 in 1 eye ("study eye"). " 12/01/2003 - "The study population was patients at least 50 years old, with best-corrected visual acuity of 20/40 to 20/200 inclusive and fluorescein angiography documenting subfoveal, classic-containing choroidal neovascularization (CNV) secondary to AMD and a lesion of greatest linear dimension <or= 5400 microm. " 01/01/2003 - "CONCLUSION: Oral fluorescein angiography using the confocal Heidelberg Retina Angiograph allowed detection of choroidal neovascularization in all patients in this study. " Order ALL the reference details at left...
5.	Neoplasms (Cancer) 12/01/2007 - "Our studies suggest that PAP-1, an 18 amino acid pH activated peptide with a pH of transition between hydrophilic and lipophilic forms (pT) of 6.4, will deliver fluorescein and 99mTc to tumors. " 06/01/2003 - "Confocal microscopic studies using fluorescein-labeled pDNA demonstrated that pDNA distributed efficiently throughout the muscle tissue whereas pDNA localization in the tumor tissue was restricted. " 06/01/1992 - "PURPOSE: The purpose of this study is to identify clinical, ultrasonographic, and fluorescein angiographic features of extramacular disciform lesions that allow differentiation from uveal tumors. " 02/01/1984 - "The double-zone fluorescein fluorescence polarization (FFP) "cancer" test was used to study 540 blood lymphocyte samples from 341 donors, of whom 158 had confirmed cancer: The other donors were noncancer patients, pregnant women, and normal individuals. " 01/01/1967 - "[Study of intra-ocular tumors using ultrasonic echography and fluorescein angiography]" Order ALL the reference details at left...

Related Drugs and Biologics

1.	isothiocyanic acid
2.	Retinaldehyde (Retinal)
3.	Indocyanine Green (Cardio-Green)
4.	Fluorescein-5-isothiocyanate (FITC)
5.	Rose Bengal
6.	Dextrans (Dextran)
7.	1-phenyl-3,3-dimethyltriazene (PDT)
8.	verteporfin (Visudyne)
9.	DNA (Deoxyribonucleic Acid)
10.	bevacizumab

Related Therapies and Procedures

1.	Light Coagulation
2.	Lasers (Laser)
3.	Vitrectomy
4.	Photochemotherapy (Photodynamic Therapy)
5.	Aftercare (After-Treatment)